FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to medicine, more specifically to pharmacology and cell engineering. What is presented is the use of hyaluronate-endo-β-N-acetylhexosaminidase immobilized on the low-molecular water-soluble carrier by ionising radiation as a drug possessing regenerative activity.
EFFECT: invention enables extending the indications for the use of hyaluronate-endo-β-N-acetylhexosaminidase immobilized on a low-molecular water-soluble carrier by ionising radiation which possess evident regenerative activity and therapeutic properties in degenerative diseases: diabetes mellitus, hepatic cirrhosis, pulmonary fibrosis and encephalopathy.
9 tbl, 7 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD OF STIMULATING LIVER STEM CELL DIFFERENTIATION IN VITRO IN TISSUE-SPECIFIC DIRECTION | 2012 |
|
RU2477752C1 |
HEPATOPROTECTOR | 2010 |
|
RU2444569C1 |
METHOD OF INCREASING STEM CELLS MOBILIZATION | 2009 |
|
RU2442601C2 |
MEDICATION FOR REGENERATIVE MEDICINE | 2009 |
|
RU2406528C2 |
AGENT FOR INCREASING RESERVED STEM CELL NUMBER IN ORGANISM | 2009 |
|
RU2405822C1 |
LIFESPAN INCREASING DRUG | 2011 |
|
RU2461389C1 |
AGENT INTENSIFYING ACTION OF BIOLOGICALLY ACTIVE SUBSTANCES AND DRUGS | 2009 |
|
RU2421239C1 |
TISSUE REGENERATION STIMULATING AGENT | 2013 |
|
RU2599289C2 |
MEANS FOR PNEUMOFIBROSIS PREVENTION AND TREATMENT AND METHOD FOR ITS PRODUCTION | 2016 |
|
RU2646810C1 |
HEMOSTIMULANT AND EXCITANT AND METHOD FOR HEMOPOIESIS STIMULATION | 2009 |
|
RU2414926C1 |
Authors
Dates
2013-04-27—Published
2011-10-05—Filed